X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/10/19/2316320/0/en/Positive-Results-from-Studies-of-Retrotope-s-RT011-in-Animal-Models-of-Retinal-Degeneration-to-be-Featured-in-Oral-Presentations-at-2nd-Annual-Dry-AMD-Therapeutic-Development-Summi.html
https://www.fiercebiotech.com/biotech/retrotope-misses-main-endpoint-but-improves-survival-late-stage-trial-ultrarare-disorder
https://www.globenewswire.com/news-release/2021/10/06/2309413/0/en/Retrotope-Reports-Data-from-Phase-2-3-Clinical-Trial-of-RT001-and-Concurrent-Natural-History-Study-in-Patients-with-Infantile-Neuroaxonal-Dystrophy-INAD.html
https://www.clinicaltrialsarena.com/analysis/retrotope-fundraise/
https://www.clinicaltrialsarena.com/analysis/retrotope-fundraise/
https://www.globenewswire.com/news-release/2021/06/30/2255495/0/en/Retrotope-Announces-Initiation-of-Phase-2-Study-of-RT001-in-Patients-with-Progressive-Supranuclear-Palsy-PSP.html
https://www.globenewswire.com/news-release/2021/04/21/2213992/0/en/Retrotope-Announces-Completion-of-Enrollment-in-Phase-2-Study-of-RT001-in-Patients-with-Amyotrophic-Lateral-Sclerosis-ALS.html#:~:text=LOS%20ALTOS%2C%20Calif.%2C%20April,clinical%20trial%20evaluating%20RT001%2C%20the
https://www.globenewswire.com/news-release/2021/03/17/2194389/0/en/Retrotope-Announces-Initiation-of-Phase-2-Study-of-RT001-in-Patients-with-Amyotrophic-Lateral-Sclerosis-ALS.html#:~:text=LOS%20ALTOS%2C%20Calif.%2C%20March,clinical%20trial%20evaluating%20RT001%2C%20the
Market Place
Share 
